T. Ozlu Et Al. , "Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis For Severity Pulmonary Embolism?," International Conference of the American-Thoracic-Society (ATS) , vol.191, Colorado, United States Of America, 2015
Ozlu, T. Et Al. 2015. Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis For Severity Pulmonary Embolism?. International Conference of the American-Thoracic-Society (ATS) , (Colorado, United States Of America).
Ozlu, T., Senturk, A., Ucar, E. Y., Berk, S., Altinsoy, B., Dabak, G., ... Cakir, E.(2015). Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis For Severity Pulmonary Embolism? . International Conference of the American-Thoracic-Society (ATS), Colorado, United States Of America
Ozlu, T. Et Al. "Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis For Severity Pulmonary Embolism?," International Conference of the American-Thoracic-Society (ATS), Colorado, United States Of America, 2015
Ozlu, T. Et Al. "Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis For Severity Pulmonary Embolism?." International Conference of the American-Thoracic-Society (ATS) , Colorado, United States Of America, 2015
Ozlu, T. Et Al. (2015) . "Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis For Severity Pulmonary Embolism?." International Conference of the American-Thoracic-Society (ATS) , Colorado, United States Of America.
@conferencepaper{conferencepaper, author={T. Ozlu Et Al. }, title={Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis For Severity Pulmonary Embolism?}, congress name={International Conference of the American-Thoracic-Society (ATS)}, city={Colorado}, country={United States Of America}, year={2015}}